Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-10-008317
Filing Date
2010-02-16
Accepted
2010-02-16 16:55:32
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL HEALTHCARE FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 v174629_sc13g-a.htm SC 13G/A 110913
  Complete submission text file 0001144204-10-008317.txt   112851
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79091 | Film No.: 10609098
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 BOYLSTON STREET, SUITE 1500 BOSTON MA 02199
Business Address 800 BOYLSTON STREET, SUITE 1500 BOSTON MA 02199 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A